Gilder, Gagnon, Howe & Co »

Alnylam Pharmaceuticals shares owned by Gilder, Gagnon, Howe & Co

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Gilder, Gagnon, Howe & Co from 13F filings

Historical chart of Gilder, Gagnon, Howe & Co investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Gilder, Gagnon, Howe & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Gilder, Gagnon, Howe & Co

Quarter filed Position value Share count Share price at filing
2013-03-31 $27M 1.1M 24.37

More positions owned by Gilder, Gagnon, Howe & Co

Tesla Motors (TSLA)
Amazon (AMZN)
Netflix (NFLX)
NVIDIA Corporation (NVDA)
Cloudflare Cl A Com (NET)
Mongodb Cl A (MDB)
Meta Platforms Cl A (META)
Duolingo Cl A Com (DUOL)
Eli Lilly & Co. (LLY)
Freshpet (FRPT)
Intuitive Surgical Com New (ISRG)
Hubspot (HUBS)
Intel Corporation (INTC)
Pool Corporation (POOL)
Shake Shack Cl A (SHAK)

View all positions for Gilder, Gagnon, Howe & Co

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
Wellington Management Company
Baillie Gifford & Co
Dodge & Cox
T. Rowe Price Associates
Jpmorgan Chase & Co
Norges Bank Investment Management
venBio Select Advisor
Legal & General Group
Bellevue Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Amundi
Gilder, Gagnon, Howe & Co
Alliancebernstein

View all funds holding Alnylam Pharmaceuticals